Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
North American Palladium Ltd. stock logo
PDL
North American Palladium
C$0.00
C$9.12
C$26.30
C$1.16BN/A133,012 shs90,733 shs
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$27.43
-0.4%
$30.70
$23.01
$50.11
$551.65M0.97225,999 shs217,267 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
North American Palladium Ltd. stock logo
PDL
North American Palladium
0.00%0.00%0.00%0.00%0.00%
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
-0.44%+4.02%-8.63%+3.24%-40.65%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
North American Palladium Ltd. stock logo
PDL
North American Palladium
N/AN/AN/AN/AN/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
3.8613 of 5 stars
3.52.01.70.02.63.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
North American Palladium Ltd. stock logo
PDL
North American Palladium
0.00
N/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
3.00
Buy$50.0082.28% Upside

Current Analyst Ratings Breakdown

Latest PDL, NTVO, SLP, and EUA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/3/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
4/16/2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$32.00 ➝ $40.00
(Data available from 6/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
North American Palladium Ltd. stock logo
PDL
North American Palladium
C$536.30M0.00N/A16.99C$10.61 per share0.00
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$78.56M7.02$0.66 per share41.50$9.12 per share3.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
North American Palladium Ltd. stock logo
PDL
North American Palladium
N/AC$3.146.29N/A0.08N/AN/AN/AN/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$9.95M$0.3568.5821.77N/A10.97%6.84%6.34%7/1/2025 (Estimated)

Latest PDL, NTVO, SLP, and EUA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/1/2025Q3 2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.29N/AN/AN/A$22.83 millionN/A
4/3/2025Q2 2025
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.25$0.31+$0.06$0.15$21.93 million$22.43 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
North American Palladium Ltd. stock logo
PDL
North American Palladium
C$0.232.72%N/A7.33%N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
$0.240.87%N/A68.57%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
North American Palladium Ltd. stock logo
PDL
North American Palladium
1.28
3.83
3.26
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
N/A
4.15
4.15

Institutional Ownership

CompanyInstitutional Ownership
North American Palladium Ltd. stock logo
PDL
North American Palladium
N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
78.08%

Insider Ownership

CompanyInsider Ownership
North American Palladium Ltd. stock logo
PDL
North American Palladium
N/A
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
19.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
North American Palladium Ltd. stock logo
PDL
North American Palladium
N/A58.84 millionN/ANot Optionable
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
16020.11 million16.19 millionOptionable

Recent News About These Companies

Simulations Plus Releases ADMET Predictor® 13
Simulations Plus Slips After Job Cuts Disclosed

New MarketBeat Followers Over Time

Media Sentiment Over Time

North American Palladium stock logo

North American Palladium TSE:PDL

North American Palladium Ltd. produces precious metals in Canada. It explores for palladium, platinum, gold, nickel, copper, and other metals. It primarily holds interest in the Lac des Iles mine that is located to the northwest of Thunder Bay, Ontario. The company was founded in 1968 and is headquartered in Toronto, Canada.

Simulations Plus stock logo

Simulations Plus NASDAQ:SLP

$27.43 -0.12 (-0.44%)
Closing price 06/9/2025 04:00 PM Eastern
Extended Trading
$27.44 +0.01 (+0.04%)
As of 06/9/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.